With just over 1.5 million page views in 2017, our learning section has covered a variety of topics this year, with CPD and learning articles ranging from managing sepsis to communicating with palliative care patients. Our peer-reviewed CPD articles have been designed to meet specific learning objectives relevant to clinical practice, and are all accompanied by an online assessment for you to test your knowledge. Our learning articles cover topics related to pharmacy practice and pharmaceutical sciences, as well as soft skills to support pharmacists in their career development.
In addition to our learning and CPD content, we also produced a successful learning campaign on foot health (in partnership with RB). The campaign aimed to improve access to high quality foot care training to meet the learning requirements of pharmacists, and support them in training the wider pharmacy team. We also launched the Pharmacy Learning Centre
on eye care (in partnership with RB, and in association with Optrex and Eye Health UK), which will continue to be developed next year.
In 2018, we will continue to add to our content library with more CPD and learning content. However, make sure you have read the most read articles of 2017:
Top five learning articles published in 2017
- Rashes in children
- Communicating with palliative care patients nearing the end of life, their families and carers
- How to identify and manage ‘problem’ excipients in medicines for children
- Advising patients on halitosis and oral hygiene
- How to support cancer patients in community pharmacies
Top five CPD articles published in 2017
- Sepsis: an update on identification and management
Clostridium difficile: diagnosis and treatment update
- Depression in adults: recognition and management
- Pharmacogenomics: an overview
- The diabetic foot
If you would like a recap on some of our articles published in 2017, you can test your knowledge in our end of year quiz.
I would be delighted to hear your feedback, receive ideas for future articles and article submissions for consideration for publication — please email me on Natasha.Leeson@rpharms.com or send me a tweet @natasha_leeson.